For the first time, the Board has approved additional funding for two shortened grants. The decision came on 14 March 2016, the same day that that the Board approved additional funding for two TB/HIV grants for Liberia from the 2014-2016 allocations.
Elimination 8 (E8) has set the formidable target of full malaria elimination in Botswana, Namibia, South Africa and Swaziland by 2020. Termed the “frontline four”, these countries are nearing elimination of the disease after achieving a 75% decline between 2000 and 2012.
Mozambique, where malaria is nationally endemic and still a major driver of mortality especially among children, is a good example of how collaboration between government, civil society and the private sector can contribute to an effective response to the disease.
A ministerial-level meeting took place on 25 March in South Africa, aiming to harmonize tracking, tracing, diagnosis and referrals for people affiliated with southern Africa's lucrative mining sector -- all of whom are at high risk for contracting tuberculosis.
The Global Fund Board has approved up to $40.5 million for four interim applicant countries: Chad, Papua New Guinea (PNG), Kenya and Mozambique. The Board decisions were based on recommendations from the Grant Approvals Committee (GAC). This brings to five the number of interim applicant countries that have received funding.
In June 2012, the Global Fund Board approved the “re-launch” of a health systems strengthening (HSS) grant in Mozambique. After two years of inactivity, the grant was re-launched as a three-year re-programmed grant. It is believed to be the first time a grant has ever been re-launched.
According to the Office of the Inspector General (OIG), in the short to medium term the Ministry of Health (MOH) in Mozambique may not be able to meet the strict requirements of the Global Fund due to limitations in capacity. The MOH is principal recipient (PR) for three active grants, one for each disease.
The Coca-Cola Company and the Global Fund are expanding a project which uses Coca-Cola’s distribution systems and business expertise to help government and non-governmental organisations deliver critical medicines to remote parts of Africa, according to a news
This table shows the same data, but in decreasing order of the amount approved for Years 1-2.